M. Vjecha

1.3k total citations · 1 hit paper
13 papers, 940 citations indexed

About

M. Vjecha is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, M. Vjecha has authored 13 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in M. Vjecha's work include Tuberculosis Research and Epidemiology (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Diagnosis and treatment of tuberculosis (3 papers). M. Vjecha is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Diagnosis and treatment of tuberculosis (3 papers). M. Vjecha collaborates with scholars based in United States, Uganda and United Kingdom. M. Vjecha's co-authors include Jerrold J. Ellner, Alphonse Okwera, Roy D. Mugerwa, John L. Johnson, Christopher C. Whalen, Simon Tiberi, Alimuddin Zumla, Robin Huebner, Giovanni Battista Migliori and David L. Hom and has published in prestigious journals such as New England Journal of Medicine, Nature Reviews Drug Discovery and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

M. Vjecha

13 papers receiving 901 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

2018 271 citations Simon Tiberi, Nelita du Plessis et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Vjecha United States	11	776	590	293	145	74	13	940
Nyasha Bakare United States	14	850 1.1×	618 1.0×	257 0.9×	288 2.0×	184 2.5×	18	1.2k
Brian Dannemann United States	12	883 1.1×	938 1.6×	262 0.9×	267 1.8×	56 0.8×	17	1.5k
Eric Nuermberger United States	19	1.2k 1.5×	831 1.4×	401 1.4×	308 2.1×	61 0.8×	21	1.4k
Pauline Howell South Africa	8	606 0.8×	383 0.6×	564 1.9×	200 1.4×	34 0.5×	20	1.2k
P C Hopewell United States	18	976 1.3×	1.0k 1.7×	398 1.4×	85 0.6×	58 0.8×	25	1.3k
James C.M. Brust United States	20	813 1.0×	687 1.2×	227 0.8×	113 0.8×	34 0.5×	34	1.0k
Liesl Page‐Shipp South Africa	14	689 0.9×	552 0.9×	218 0.7×	79 0.5×	38 0.5×	27	853
Aliasgar Esmail South Africa	18	745 1.0×	532 0.9×	297 1.0×	78 0.5×	65 0.9×	57	955
Giorgio Besozzi Italy	17	785 1.0×	612 1.0×	316 1.1×	179 1.2×	72 1.0×	43	971
Gopalan Narendran India	20	849 1.1×	696 1.2×	458 1.6×	88 0.6×	166 2.2×	49	1.2k

Countries citing papers authored by M. Vjecha

Since Specialization

Citations

This map shows the geographic impact of M. Vjecha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Vjecha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Vjecha more than expected).

Fields of papers citing papers by M. Vjecha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Vjecha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Vjecha. The network helps show where M. Vjecha may publish in the future.

Co-authorship network of co-authors of M. Vjecha

This figure shows the co-authorship network connecting the top 25 collaborators of M. Vjecha. A scholar is included among the top collaborators of M. Vjecha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Vjecha. M. Vjecha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tiberi, Simon, et al.. (2021). Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. International Journal of Infectious Diseases. 113. S96–S99. 38 indexed citations

Vjecha, M., Simon Tiberi, & Alimuddin Zumla. (2018). Accelerating the development of therapeutic strategies for drug-resistant tuberculosis. Nature Reviews Drug Discovery. 17(9). 607–608. 22 indexed citations

Tiberi, Simon, Nelita du Plessis, Gerhard Walzl, et al.. (2018). Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. The Lancet Infectious Diseases. 18(7). e183–e198. 271 indexed citations breakdown →

Vjecha, M., Simon Tiberi, & Alimuddin Zumla. (2018). Erratum: Accelerating the development of therapeutic strategies for drug-resistant tuberculosis. Nature Reviews Drug Discovery. 17(5). 377–377. 1 indexed citations

Johnson, John L., M. Vjecha, Kathy Wolski, et al.. (1998). Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.. PubMed. 2(5). 397–404. 49 indexed citations

Pekovic, Vukosava, M. Vjecha, John L. Johnson, et al.. (1998). Comparison of Three Composite Compliance Indices in a Trial of Self-Administered Preventive Therapy for Tuberculosis in HIV-Infected Ugandan Adults. Journal of Clinical Epidemiology. 51(7). 597–607. 22 indexed citations

Johnson, Joy L., Alphonse Okwera, M. Vjecha, et al.. (1997). Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.. PubMed. 1(5). 446–53. 28 indexed citations

Whalen, Christopher C., John L. Johnson, Alphonse Okwera, et al.. (1997). A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus. New England Journal of Medicine. 337(12). 801–808. 297 indexed citations

Okwera, Alphonse, John L. Johnson, M. Vjecha, et al.. (1996). Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. Pneumologie. 50(10). 732–733. 2 indexed citations

10.

Whalen, Christopher C., Alphonse Okwera, John L. Johnson, et al.. (1996). Predictors of Survival in Human Immunodeficiency Virus-Infected Patients With Pulmonary Tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration. American Journal of Respiratory and Critical Care Medicine. 153(6). 1977–1981. 45 indexed citations

11.

Wallis, Robert S., Marion S. Helfand, Christopher C. Whalen, et al.. (1996). Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis. Tubercle and Lung Disease. 77(6). 516–523. 33 indexed citations

12.

Daniel, T M, Alphonse Okwera, T. Aisu, et al.. (1994). Reduced sensitivity of tuberculosis serodiagnosis in patients with AIDS in Uganda. Tubercle and Lung Disease. 75(1). 33–37. 19 indexed citations

13.

Wallis, Robert S., et al.. (1993). Influence of Tuberculosis on Human Immunodeficiency Virus (HIV-1): Enhanced Cytokine Expression and Elevated 2-Microglobulin in HIV-1-Associated Tuberculosis. The Journal of Infectious Diseases. 167(1). 43–48. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact